Why is Link Pharma Chem falling/rising?

As of 29-Aug, Link Pharma Chem Ltd is currently priced at 33.15, reflecting an increase of 0.49 or 1.5%. The stock has shown a trend reversal, gaining after four consecutive days of decline. Despite this recent uptick, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, Link Pharma Chem has underperformed the benchmark Sensex, with a return of -7.63% compared to the Sensex's -1.84%. Additionally, the company has faced significant challenges, including a weak long-term fundamental strength indicated by a -183.49% CAGR growth in operating profits over the last five years and a negative return on equity of 5.21%. The company's net sales and profit after tax have also shown a decline of -21.03% in the last nine months, contributing to its perception as a risky investment.
In the broader market context, Link Pharma Chem's recent performance contrasts with the Sensex, which has shown a slight decline of -1.84% over the same period. While the stock has outperformed its sector today by 1.95%, its long-term performance remains concerning, with a -24.38% return over the past year. The rising investor participation, indicated by a significant increase in delivery volume, may suggest some renewed interest, but the overall negative operating profits and poor ability to service debt continue to weigh heavily on investor sentiment. The stock's liquidity is adequate for trading, but the underlying financial weaknesses suggest that the recent price movement may not be sustainable in the long term.